60 participants
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-04-30
- Start Date:
- 2026-04-06
- Completion:
- 2026-06-30
Conditions
- Pharmacokinetics
- Pharmacodynamics
- Insulin Aspart
Interventions
- DRUG
No Results Yet